Bridgehead offers a powerful combination of strategic, technical and commercial consultacy expertise across all therapy areas in the pharmaceutical, biotechnology, medical device and diagnostics sectors, to support companies and investors in:
Most of this work is highly confidential, but published examples are the Independent Experts’ Reports prepared to support fundraising via the London Stock Exchange, UK Alternative Investment Market and other public stock markets. These include reports on companies such as: Vectura Group plc, ProStrakan Group plc, BioTie Therapies Corp. and Tyrell Inc., which were prepared for advisors including: Morgan Stanley, Credit Suisse, Piper Jaffray and Nomura Code.
For further information please contact us now.
